受託研究機構市場規模、佔有率和成長分析（按治療領域、最終用戶和地區分類）—產業預測（2026-2033 年）

全球受託研究機構(CRO) 市場規模預計在 2024 年達到 751 億美元，從 2025 年的 822.3 億美元成長到 2033 年的 1699.7 億美元，在預測期（2026-2033 年）內複合年成長率為 9.5%。

由於醫療保健領域外包趨勢的日益成長以及全球製造成本的上升，受託研究機構）市場預計將迎來顯著成長。醫療研究投資的增加和臨床試驗的激增預計將極大地惠及CRO。藥物研發流程的日益複雜化進一步推動了全球範圍內對CRO的需求。透過利用CRO，醫療機構可以在不影響其業務目標的前提下，有效降低成本並提高盈利。新興市場有利的法規環境也為市場成長開闢了新的途徑。然而，智慧財產權問題、對製藥客戶的依賴以及CRO之間激烈的競爭等挑戰可能會限制市場擴張。

全球受託研究機構市場促進因素

全球受託研究機構)市場的主要驅動力是醫療保健領域外包趨勢的不斷擴大，而這一趨勢又源於對資源日益成長的需求。製藥和生物技術公司越來越依賴 CRO 來推進臨床研究、藥物開發和監管支援。這種外包策略有助於提高成本效益、獲得專業知識並加快新藥上市速度。 CRO 對現代醫療保健至關重要，它們對藥物開發的各個階段都產生重大影響，並幫助企業有效地應對複雜的科研環境。

限制全球受託研究機構市場的因素

由於製藥和生技公司日益關注智慧財產權保護，全球受託研究機構）市場面臨許多限制因素。這些公司在與CRO合作時，為了保護其專有訊息，可能會因為擔心潛在的智慧財產權侵權或盜用而完全放棄外包。這種顧慮可能會限制CRO服務的普及，並最終限制CRO在市場上的影響力和潛力。因此，儘管CRO在藥物研發領域發揮著舉足輕重的作用，但這些顧慮仍對整個CRO產業的成長和擴張構成挑戰。

全球受託研究機構市場趨勢

全球受託研究機構 ( CRO) 市場的主要趨勢之一是，精準醫療和個人化醫療的進步推動了對專業化服務的需求不斷成長。隨著製藥和生物技術公司尋求簡化臨床試驗和藥物開發流程，CRO 也在不斷發展，為特定治療領域和患者群體提供客製化解決方案。此外，人工智慧和真實世界數據 (RWE) 等創新技術的整合正在改變營運能力，增強數據分析能力，並改善患者招募策略，使 CRO 成為快速發展的醫療保健環境中不可或缺的合作夥伴。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 一手和二手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管分析
• 技術分析
• 用例

全球受託研究機構市場規模（按類型和複合年成長率分類）（2026-2033 年）

• 藥物發現
• 非臨床測試
• 實驗室測試
• 其他

全球受託研究機構市場規模（依治療領域分類）及複合年成長率（2026-2033 年）

• 腫瘤學
• 循環系統
• 感染疾病
• 神經病學
• 免疫疾病
• 胃腸病學和肝病學
• 其他

全球受託研究機構市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 製藥和生物技術公司
• 醫療設備製造商
• 其他

全球受託研究機構市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • GCC
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

  主要企業簡介

  • ICON plc（愛爾蘭）
  • Medpace（美國）
  • Fortrea（美國）
  • 賽默飛世爾科技（美國）
  • PPD公司（美國）
  • Labcorp 藥物開發（美國）
  • Eurofins Scientific（法國）
  • SGS SA（瑞士）
  • PSI CRO AG（瑞士）
  • KCR SA（波蘭）
  • Linical Co., Ltd.（日本）
  • Pharmaron（中國）
  • 藥明生物（中國）
  • 泰格醫藥（中國）

結論與建議

Global Contract Research Organization Market size was valued at USD 75.10 Billion in 2024 and is poised to grow from USD 82.23 Billion in 2025 to USD 169.97 Billion by 2033, growing at a CAGR of 9.5% during the forecast period (2026-2033).

The contract research organization (CRO) market is set for significant growth driven by the escalating trend of outsourcing within the healthcare sector and rising global manufacturing costs. Increased investment in medical research and a surge in clinical trials are anticipated to benefit CROs substantially. The complexity involved in drug development processes further fuels the demand for these organizations on a global scale. By leveraging CROs, healthcare entities can effectively reduce expenses and enhance profitability without sacrificing their business objectives. Favorable regulatory conditions in emerging markets also present new avenues for growth. However, challenges such as intellectual property issues, reliance on pharmaceutical clients, and intense competition among CROs may limit market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Contract Research Organization market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Contract Research Organization Market Segments Analysis

Global Contract Research Organization Market is segmented by Type, Therapeutic Area, End-User and region. Based on Type, the market is segmented into Drug Discovery, Pre-Clinical, Clinical and Others. Based on Therapeutic Area, the market is segmented intoOncology, Cardiology, Infectious Disease, Neurology, Immunological Disorders, Gastroenterology and Hepatology and Others. Based on End-User, the market is segmented into Pharmaceutical and Biotechnological Companies, Medical Device Companies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Contract Research Organization Market

The Global Contract Research Organization (CRO) market is primarily driven by the growing trend of outsourcing within the healthcare sector, fueled by the rising demand for resources. Pharmaceutical and biotech firms increasingly rely on CROs to facilitate clinical research, drug development, and regulatory assistance. This outsourcing strategy contributes to cost efficiency, provides access to specialized knowledge, and enhances the speed at which new drugs reach the market. CROs are essential to contemporary healthcare, significantly influencing various phases of pharmaceutical development and ensuring that companies can navigate complex research landscapes effectively.

Restraints in the Global Contract Research Organization Market

The Global Contract Research Organization (CRO) market faces significant constraints due to increasing concerns regarding the protection of intellectual property rights among pharmaceutical and biotech companies. As these organizations seek to safeguard their proprietary information while engaging with CROs, the fear of potential intellectual property infringements or misappropriation may lead them to avoid outsourcing altogether. This reluctance can restrict the adoption of CRO services, ultimately limiting their influence and potential within the market. Consequently, such apprehensions pose a challenge to the overall growth and expansion of the CRO sector, despite its established role in advancing drug development and research initiatives.

Market Trends of the Global Contract Research Organization Market

A key market trend in the Global Contract Research Organization (CRO) sector is the increasing demand for specialized services driven by advancements in precision medicine and personalized healthcare. As pharmaceutical and biotechnology companies seek to optimize clinical trial efficiencies and streamline drug development processes, CROs are evolving to offer tailored solutions that address specific therapeutic areas and patient populations. Furthermore, the integration of innovative technologies such as artificial intelligence and real-world evidence is transforming operational capabilities, enhancing data analysis, and improving patient recruitment strategies, thereby positioning CROs as essential partners in the rapid evolution of the healthcare landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis
• Case Studies

Global Contract Research Organization Market Size by Type & CAGR (2026-2033)

• Market Overview
• Drug Discovery
• Pre-Clinical
• Clinical
• Others

Global Contract Research Organization Market Size by Therapeutic Area & CAGR (2026-2033)

• Market Overview
• Oncology
• Cardiology
• Infectious Disease
• Neurology
• Immunological Disorders
• Gastroenterology and Hepatology
• Others

Global Contract Research Organization Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical and Biotechnological Companies
• Medical Device Companies
• Others

Global Contract Research Organization Market Size & CAGR (2026-2033)

• North America (Type, Therapeutic Area, End-User)
  • US
  • Canada
• Europe (Type, Therapeutic Area, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Therapeutic Area, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Therapeutic Area, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Therapeutic Area, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• ICON plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medpace (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fortrea (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PPD Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Labcorp Drug Development (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGS SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PSI CRO AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KCR S.A. (Poland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Linical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharmaron (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi Biologics (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tigermed (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations